nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent—PTGS2—Etoposide—uterine cancer	0.0424	0.542	CbGbCtD
Icosapent—PTGS1—Etoposide—uterine cancer	0.0358	0.458	CbGbCtD
Icosapent—Haemorrhagic disorder—Medroxyprogesterone Acetate—uterine cancer	0.0259	0.188	CcSEcCtD
Icosapent—ACSL3—renal system—uterine cancer	0.0171	0.0385	CbGeAlD
Icosapent—SLC8A1—smooth muscle tissue—uterine cancer	0.0148	0.0331	CbGeAlD
Icosapent—SLC8A1—renal system—uterine cancer	0.0142	0.0319	CbGeAlD
Icosapent—ACSL3—female reproductive system—uterine cancer	0.0137	0.0308	CbGeAlD
Icosapent—FADS1—myometrium—uterine cancer	0.013	0.0292	CbGeAlD
Icosapent—ACSL3—female gonad—uterine cancer	0.0125	0.0281	CbGeAlD
Icosapent—ACSL4—myometrium—uterine cancer	0.0118	0.0266	CbGeAlD
Icosapent—SLC8A1—female reproductive system—uterine cancer	0.0114	0.0256	CbGeAlD
Icosapent—PPARG—artery—uterine cancer	0.011	0.0247	CbGeAlD
Icosapent—PPARG—Teniposide—Etoposide—uterine cancer	0.0107	1	CbGdCrCtD
Icosapent—TRPV1—epithelium—uterine cancer	0.0102	0.023	CbGeAlD
Icosapent—FADS1—uterine cervix—uterine cancer	0.0101	0.0228	CbGeAlD
Icosapent—FADS1—smooth muscle tissue—uterine cancer	0.00985	0.0221	CbGeAlD
Icosapent—FADS1—decidua—uterine cancer	0.00965	0.0217	CbGeAlD
Icosapent—TRPV1—renal system—uterine cancer	0.00948	0.0213	CbGeAlD
Icosapent—ACSL4—uterine cervix—uterine cancer	0.0092	0.0207	CbGeAlD
Icosapent—FADS1—endometrium—uterine cancer	0.00917	0.0206	CbGeAlD
Icosapent—PTGS1—oviduct—uterine cancer	0.00889	0.02	CbGeAlD
Icosapent—FADS1—mammalian vulva—uterine cancer	0.00887	0.0199	CbGeAlD
Icosapent—PPARD—uterine cervix—uterine cancer	0.00883	0.0198	CbGeAlD
Icosapent—ACSL4—decidua—uterine cancer	0.00877	0.0197	CbGeAlD
Icosapent—ACSL4—renal system—uterine cancer	0.00861	0.0193	CbGeAlD
Icosapent—FADS1—uterus—uterine cancer	0.00845	0.019	CbGeAlD
Icosapent—PPARD—decidua—uterine cancer	0.00842	0.0189	CbGeAlD
Icosapent—FABP7—female reproductive system—uterine cancer	0.00837	0.0188	CbGeAlD
Icosapent—ACSL4—endometrium—uterine cancer	0.00832	0.0187	CbGeAlD
Icosapent—ACSL4—mammalian vulva—uterine cancer	0.00805	0.0181	CbGeAlD
Icosapent—PPARD—mammalian vulva—uterine cancer	0.00773	0.0174	CbGeAlD
Icosapent—ACSL4—uterus—uterine cancer	0.00767	0.0172	CbGeAlD
Icosapent—TRPV1—female reproductive system—uterine cancer	0.00759	0.0171	CbGeAlD
Icosapent—Eructation—Progesterone—uterine cancer	0.0071	0.0515	CcSEcCtD
Icosapent—FADS1—female gonad—uterine cancer	0.00691	0.0155	CbGeAlD
Icosapent—ACSL4—female reproductive system—uterine cancer	0.00689	0.0155	CbGeAlD
Icosapent—FADS1—vagina—uterine cancer	0.00687	0.0154	CbGeAlD
Icosapent—PPARD—female reproductive system—uterine cancer	0.00662	0.0149	CbGeAlD
Icosapent—ACSL4—female gonad—uterine cancer	0.00627	0.0141	CbGeAlD
Icosapent—ACSL4—vagina—uterine cancer	0.00624	0.014	CbGeAlD
Icosapent—PPARD—female gonad—uterine cancer	0.00602	0.0135	CbGeAlD
Icosapent—PPARD—vagina—uterine cancer	0.00599	0.0134	CbGeAlD
Icosapent—PTGS1—artery—uterine cancer	0.00589	0.0132	CbGeAlD
Icosapent—PTGS2—artery—uterine cancer	0.00563	0.0126	CbGeAlD
Icosapent—Aspartate aminotransferase increased—Progesterone—uterine cancer	0.00473	0.0343	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Progesterone—uterine cancer	0.00463	0.0336	CcSEcCtD
Icosapent—FADS1—lymph node—uterine cancer	0.00444	0.00997	CbGeAlD
Icosapent—Alanine aminotransferase increased—Medroxyprogesterone Acetate—uterine cancer	0.00419	0.0304	CcSEcCtD
Icosapent—PPARG—epithelium—uterine cancer	0.00418	0.00938	CbGeAlD
Icosapent—ACSL4—lymph node—uterine cancer	0.00403	0.00906	CbGeAlD
Icosapent—PPARG—smooth muscle tissue—uterine cancer	0.00402	0.00903	CbGeAlD
Icosapent—PPARG—decidua—uterine cancer	0.00394	0.00886	CbGeAlD
Icosapent—PPARG—renal system—uterine cancer	0.00387	0.0087	CbGeAlD
Icosapent—PPARD—lymph node—uterine cancer	0.00387	0.0087	CbGeAlD
Icosapent—PPARG—mammalian vulva—uterine cancer	0.00362	0.00813	CbGeAlD
Icosapent—PPARG—uterus—uterine cancer	0.00345	0.00775	CbGeAlD
Icosapent—Aspartate aminotransferase increased—Dactinomycin—uterine cancer	0.00334	0.0242	CcSEcCtD
Icosapent—Malnutrition—Progesterone—uterine cancer	0.00316	0.0229	CcSEcCtD
Icosapent—PPARG—female reproductive system—uterine cancer	0.0031	0.00697	CbGeAlD
Icosapent—Malnutrition—Medroxyprogesterone Acetate—uterine cancer	0.00286	0.0208	CcSEcCtD
Icosapent—PPARG—female gonad—uterine cancer	0.00282	0.00634	CbGeAlD
Icosapent—PPARG—vagina—uterine cancer	0.00281	0.0063	CbGeAlD
Icosapent—Dysgeusia—Medroxyprogesterone Acetate—uterine cancer	0.0028	0.0203	CcSEcCtD
Icosapent—PTGS2—myometrium—uterine cancer	0.00272	0.0061	CbGeAlD
Icosapent—Arthralgia—Progesterone—uterine cancer	0.00269	0.0195	CcSEcCtD
Icosapent—Anaphylactic shock—Progesterone—uterine cancer	0.00258	0.0187	CcSEcCtD
Icosapent—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.00244	0.0177	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Etoposide—uterine cancer	0.00237	0.0172	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00235	0.017	CcSEcCtD
Icosapent—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00234	0.0169	CcSEcCtD
Icosapent—Dyspepsia—Progesterone—uterine cancer	0.00227	0.0165	CcSEcCtD
Icosapent—PTGS1—epithelium—uterine cancer	0.00223	0.00501	CbGeAlD
Icosapent—Gastrointestinal disorder—Progesterone—uterine cancer	0.00223	0.0161	CcSEcCtD
Icosapent—PTGS1—uterine cervix—uterine cancer	0.00221	0.00497	CbGeAlD
Icosapent—Constipation—Progesterone—uterine cancer	0.00221	0.016	CcSEcCtD
Icosapent—PTGS1—smooth muscle tissue—uterine cancer	0.00215	0.00483	CbGeAlD
Icosapent—PTGS2—epithelium—uterine cancer	0.00213	0.00479	CbGeAlD
Icosapent—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00213	0.0154	CcSEcCtD
Icosapent—PTGS2—uterine cervix—uterine cancer	0.00212	0.00475	CbGeAlD
Icosapent—PTGS1—renal system—uterine cancer	0.00207	0.00465	CbGeAlD
Icosapent—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00206	0.0149	CcSEcCtD
Icosapent—PTGS2—smooth muscle tissue—uterine cancer	0.00206	0.00462	CbGeAlD
Icosapent—Eructation—Epirubicin—uterine cancer	0.00204	0.0148	CcSEcCtD
Icosapent—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00202	0.0146	CcSEcCtD
Icosapent—PTGS1—endometrium—uterine cancer	0.002	0.0045	CbGeAlD
Icosapent—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.002	0.0145	CcSEcCtD
Icosapent—PTGS2—renal system—uterine cancer	0.00198	0.00444	CbGeAlD
Icosapent—PTGS1—mammalian vulva—uterine cancer	0.00194	0.00435	CbGeAlD
Icosapent—PTGS2—endometrium—uterine cancer	0.00191	0.0043	CbGeAlD
Icosapent—Eructation—Doxorubicin—uterine cancer	0.00188	0.0137	CcSEcCtD
Icosapent—PTGS1—uterus—uterine cancer	0.00184	0.00414	CbGeAlD
Icosapent—Pruritus—Progesterone—uterine cancer	0.00182	0.0132	CcSEcCtD
Icosapent—PPARG—lymph node—uterine cancer	0.00181	0.00407	CbGeAlD
Icosapent—PTGS2—uterus—uterine cancer	0.00176	0.00396	CbGeAlD
Icosapent—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00166	0.012	CcSEcCtD
Icosapent—PTGS1—female reproductive system—uterine cancer	0.00166	0.00372	CbGeAlD
Icosapent—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00165	0.012	CcSEcCtD
Icosapent—Vomiting—Progesterone—uterine cancer	0.00164	0.0119	CcSEcCtD
Icosapent—Rash—Progesterone—uterine cancer	0.00163	0.0118	CcSEcCtD
Icosapent—Dermatitis—Progesterone—uterine cancer	0.00162	0.0118	CcSEcCtD
Icosapent—PTGS2—female reproductive system—uterine cancer	0.00158	0.00356	CbGeAlD
Icosapent—Dysgeusia—Etoposide—uterine cancer	0.00158	0.0115	CcSEcCtD
Icosapent—PTGS1—female gonad—uterine cancer	0.00151	0.00339	CbGeAlD
Icosapent—PTGS1—vagina—uterine cancer	0.0015	0.00337	CbGeAlD
Icosapent—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00149	0.0108	CcSEcCtD
Icosapent—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00147	0.0107	CcSEcCtD
Icosapent—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00147	0.0107	CcSEcCtD
Icosapent—PTGS2—female gonad—uterine cancer	0.00144	0.00324	CbGeAlD
Icosapent—PTGS2—vagina—uterine cancer	0.00143	0.00322	CbGeAlD
Icosapent—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.00135	0.00982	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.00133	0.00962	CcSEcCtD
Icosapent—Anaphylactic shock—Etoposide—uterine cancer	0.00132	0.00957	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.00125	0.00909	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.00123	0.0089	CcSEcCtD
Icosapent—Vomiting—Dactinomycin—uterine cancer	0.00116	0.0084	CcSEcCtD
Icosapent—Rash—Dactinomycin—uterine cancer	0.00115	0.00833	CcSEcCtD
Icosapent—Gastrointestinal disorder—Etoposide—uterine cancer	0.00114	0.00826	CcSEcCtD
Icosapent—Constipation—Etoposide—uterine cancer	0.00113	0.00818	CcSEcCtD
Icosapent—PTGS1—lymph node—uterine cancer	0.00097	0.00218	CbGeAlD
Icosapent—Pruritus—Etoposide—uterine cancer	0.000933	0.00677	CcSEcCtD
Icosapent—PTGS2—lymph node—uterine cancer	0.000927	0.00208	CbGeAlD
Icosapent—Malnutrition—Epirubicin—uterine cancer	0.000906	0.00657	CcSEcCtD
Icosapent—Dysgeusia—Epirubicin—uterine cancer	0.000887	0.00643	CcSEcCtD
Icosapent—Vomiting—Etoposide—uterine cancer	0.000839	0.00608	CcSEcCtD
Icosapent—Malnutrition—Doxorubicin—uterine cancer	0.000838	0.00608	CcSEcCtD
Icosapent—Rash—Etoposide—uterine cancer	0.000832	0.00603	CcSEcCtD
Icosapent—Dermatitis—Etoposide—uterine cancer	0.000831	0.00603	CcSEcCtD
Icosapent—Dysgeusia—Doxorubicin—uterine cancer	0.000821	0.00595	CcSEcCtD
Icosapent—Arthralgia—Epirubicin—uterine cancer	0.000771	0.00559	CcSEcCtD
Icosapent—Anaphylactic shock—Epirubicin—uterine cancer	0.00074	0.00536	CcSEcCtD
Icosapent—Arthralgia—Doxorubicin—uterine cancer	0.000714	0.00518	CcSEcCtD
Icosapent—Anaphylactic shock—Doxorubicin—uterine cancer	0.000684	0.00496	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000674	0.00488	CcSEcCtD
Icosapent—Dyspepsia—Epirubicin—uterine cancer	0.000651	0.00472	CcSEcCtD
Icosapent—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000638	0.00463	CcSEcCtD
Icosapent—Constipation—Epirubicin—uterine cancer	0.000632	0.00459	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000623	0.00452	CcSEcCtD
Icosapent—Dyspepsia—Doxorubicin—uterine cancer	0.000602	0.00437	CcSEcCtD
Icosapent—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000591	0.00428	CcSEcCtD
Icosapent—Constipation—Doxorubicin—uterine cancer	0.000585	0.00424	CcSEcCtD
Icosapent—Pruritus—Epirubicin—uterine cancer	0.000523	0.00379	CcSEcCtD
Icosapent—Pruritus—Doxorubicin—uterine cancer	0.000484	0.00351	CcSEcCtD
Icosapent—Vomiting—Epirubicin—uterine cancer	0.00047	0.00341	CcSEcCtD
Icosapent—Rash—Epirubicin—uterine cancer	0.000466	0.00338	CcSEcCtD
Icosapent—Dermatitis—Epirubicin—uterine cancer	0.000466	0.00338	CcSEcCtD
Icosapent—Vomiting—Doxorubicin—uterine cancer	0.000435	0.00315	CcSEcCtD
Icosapent—Rash—Doxorubicin—uterine cancer	0.000431	0.00313	CcSEcCtD
Icosapent—Dermatitis—Doxorubicin—uterine cancer	0.000431	0.00313	CcSEcCtD
Icosapent—PPARG—Generic Transcription Pathway—PGR—uterine cancer	0.00037	0.00113	CbGpPWpGaD
Icosapent—PPARG—PPARA activates gene expression—EP300—uterine cancer	0.000369	0.00112	CbGpPWpGaD
Icosapent—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—uterine cancer	0.000367	0.00112	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	0.000364	0.00111	CbGpPWpGaD
Icosapent—PTGS2—Selenium Micronutrient Network—CCL2—uterine cancer	0.000362	0.0011	CbGpPWpGaD
Icosapent—PPARD—Generic Transcription Pathway—ESR1—uterine cancer	0.000361	0.0011	CbGpPWpGaD
Icosapent—PPARD—Metabolism—POLD1—uterine cancer	0.000361	0.0011	CbGpPWpGaD
Icosapent—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—uterine cancer	0.000361	0.0011	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—STK11—uterine cancer	0.00036	0.0011	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—CYP19A1—uterine cancer	0.00036	0.0011	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—CYP19A1—uterine cancer	0.00036	0.0011	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—STK11—uterine cancer	0.00036	0.0011	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—YWHAE—uterine cancer	0.00036	0.0011	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—MTHFR—uterine cancer	0.000357	0.00109	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—SUZ12—uterine cancer	0.000357	0.00109	CbGpPWpGaD
Icosapent—FADS1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	0.000357	0.00109	CbGpPWpGaD
Icosapent—PPARG—Metabolism—NDUFB11—uterine cancer	0.000348	0.00106	CbGpPWpGaD
Icosapent—PPARG—Metabolism—SRD5A2—uterine cancer	0.000348	0.00106	CbGpPWpGaD
Icosapent—PPARG—Adipogenesis—CTNNB1—uterine cancer	0.000347	0.00106	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—FBXW7—uterine cancer	0.000345	0.00105	CbGpPWpGaD
Icosapent—ACSL4—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	0.000338	0.00103	CbGpPWpGaD
Icosapent—PPARD—Metabolism—AKR1C1—uterine cancer	0.000338	0.00103	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000338	0.00103	CbGpPWpGaD
Icosapent—PTGS2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	0.000332	0.00101	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	0.000331	0.00101	CbGpPWpGaD
Icosapent—PTGS2—C-MYB transcription factor network—CDKN2A—uterine cancer	0.000327	0.000998	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—EP300—uterine cancer	0.000327	0.000997	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—PGR—uterine cancer	0.000326	0.000994	CbGpPWpGaD
Icosapent—PPARG—Generic Transcription Pathway—ESR2—uterine cancer	0.000325	0.000992	CbGpPWpGaD
Icosapent—FFAR1—Metabolism of proteins—CXCL8—uterine cancer	0.000325	0.000991	CbGpPWpGaD
Icosapent—PPARG—SREBP signalling—AKT1—uterine cancer	0.000324	0.000987	CbGpPWpGaD
Icosapent—ACSL4—Metabolism of lipids and lipoproteins—EP300—uterine cancer	0.000323	0.000984	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000319	0.000972	CbGpPWpGaD
Icosapent—ACSL3—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	0.000315	0.00096	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000314	0.000957	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000314	0.000957	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—VEGFA—uterine cancer	0.00031	0.000945	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—EZH2—uterine cancer	0.000309	0.000944	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—NRAS—uterine cancer	0.000306	0.000933	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—STK11—uterine cancer	0.000301	0.000919	CbGpPWpGaD
Icosapent—PPARD—Metabolism—RRM2—uterine cancer	0.000301	0.000918	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—CCL2—uterine cancer	0.0003	0.000915	CbGpPWpGaD
Icosapent—FFAR1—Metabolism of proteins—CTNNB1—uterine cancer	0.0003	0.000915	CbGpPWpGaD
Icosapent—FADS1—Metabolism—MTHFR—uterine cancer	0.000299	0.000913	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	0.000296	0.000904	CbGpPWpGaD
Icosapent—PPARD—Metabolism—DCN—uterine cancer	0.000292	0.000891	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.00029	0.000885	CbGpPWpGaD
Icosapent—PTGS2—C-MYB transcription factor network—CDKN1B—uterine cancer	0.00029	0.000883	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—ESR2—uterine cancer	0.000287	0.000875	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—CCL2—uterine cancer	0.000286	0.000872	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—SOCS3—uterine cancer	0.000282	0.000861	CbGpPWpGaD
Icosapent—PTGS2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	0.000282	0.00086	CbGpPWpGaD
Icosapent—PPARD—Metabolism—CYP11A1—uterine cancer	0.000275	0.00084	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—MTHFR—uterine cancer	0.000271	0.000826	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—MTHFR—uterine cancer	0.000271	0.000826	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CDKN2B—uterine cancer	0.00027	0.000824	CbGpPWpGaD
Icosapent—PPARG—Generic Transcription Pathway—CDKN2B—uterine cancer	0.000265	0.000808	CbGpPWpGaD
Icosapent—FADS1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	0.000264	0.000805	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—KRAS—uterine cancer	0.000263	0.000803	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—IGF1R—uterine cancer	0.000262	0.0008	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—CXCL8—uterine cancer	0.000261	0.000796	CbGpPWpGaD
Icosapent—PPARD—Metabolism—AKR1C3—uterine cancer	0.00026	0.000793	CbGpPWpGaD
Icosapent—PTGS2—C-MYB transcription factor network—EP300—uterine cancer	0.000254	0.000776	CbGpPWpGaD
Icosapent—PPARG—Metabolism—STAR—uterine cancer	0.000251	0.000766	CbGpPWpGaD
Icosapent—PPARG—Metabolism—AKR1B1—uterine cancer	0.000251	0.000766	CbGpPWpGaD
Icosapent—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	0.000249	0.000758	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000248	0.000757	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—SMAD3—uterine cancer	0.000247	0.000752	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—NDUFB11—uterine cancer	0.000243	0.000742	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—SRD5A2—uterine cancer	0.000243	0.000742	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—PIK3CA—uterine cancer	0.000242	0.000738	CbGpPWpGaD
Icosapent—PPARG—Generic Transcription Pathway—SMAD3—uterine cancer	0.000242	0.000737	CbGpPWpGaD
Icosapent—PPARG—Circadian rythm related genes—PTEN—uterine cancer	0.000239	0.000728	CbGpPWpGaD
Icosapent—ACSL4—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	0.000239	0.000728	CbGpPWpGaD
Icosapent—PTGS2—C-MYB transcription factor network—NRAS—uterine cancer	0.000238	0.000726	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—CXCL8—uterine cancer	0.000237	0.000723	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000236	0.000721	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—FGFR2—uterine cancer	0.000235	0.000717	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—TP53—uterine cancer	0.000234	0.000714	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—CDKN2B—uterine cancer	0.000234	0.000712	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.00023	0.000702	CbGpPWpGaD
Icosapent—PPARG—Circadian rythm related genes—EP300—uterine cancer	0.000228	0.000694	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—SMAD3—uterine cancer	0.000228	0.000694	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—CXCL8—uterine cancer	0.000226	0.000689	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—HRAS—uterine cancer	0.000224	0.000683	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000223	0.000681	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	0.000221	0.000674	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—CDKN1B—uterine cancer	0.000221	0.000673	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—SMAD3—uterine cancer	0.000213	0.00065	CbGpPWpGaD
Icosapent—PTGS2—C-MYB transcription factor network—KRAS—uterine cancer	0.000205	0.000625	CbGpPWpGaD
Icosapent—PPARD—Metabolism—STK11—uterine cancer	0.000203	0.000618	CbGpPWpGaD
Icosapent—PPARD—Metabolism—CYP19A1—uterine cancer	0.000203	0.000618	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—ESR1—uterine cancer	0.000201	0.000614	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—PTEN—uterine cancer	0.000199	0.000606	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—AKT1—uterine cancer	0.000198	0.000603	CbGpPWpGaD
Icosapent—PPARG—Generic Transcription Pathway—ESR1—uterine cancer	0.000197	0.000602	CbGpPWpGaD
Icosapent—PPARG—Metabolism—POLD1—uterine cancer	0.000197	0.000601	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—SRD5A2—uterine cancer	0.000193	0.000589	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—NDUFB11—uterine cancer	0.000193	0.000589	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—NRAS—uterine cancer	0.00019	0.00058	CbGpPWpGaD
Icosapent—PPARD—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	0.00019	0.00058	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—EP300—uterine cancer	0.00019	0.000578	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000188	0.000572	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—MET—uterine cancer	0.000187	0.000569	CbGpPWpGaD
Icosapent—PPARG—Metabolism—AKR1C1—uterine cancer	0.000184	0.000562	CbGpPWpGaD
Icosapent—PPARD—Metabolism of lipids and lipoproteins—EP300—uterine cancer	0.000181	0.000553	CbGpPWpGaD
Icosapent—PTGS2—Disease—AKR1B10—uterine cancer	0.000179	0.000547	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—PGR—uterine cancer	0.000178	0.000543	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000177	0.000541	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CCL2—uterine cancer	0.000177	0.00054	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—AKR1B1—uterine cancer	0.000176	0.000537	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—STAR—uterine cancer	0.000176	0.000537	CbGpPWpGaD
Icosapent—PTGS2—C-MYB transcription factor network—HRAS—uterine cancer	0.000174	0.000531	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—ESR1—uterine cancer	0.000174	0.000531	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000174	0.000531	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—EZH2—uterine cancer	0.000169	0.000515	CbGpPWpGaD
Icosapent—FADS1—Metabolism—PTEN—uterine cancer	0.000167	0.000508	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—PIK3CA—uterine cancer	0.000166	0.000505	CbGpPWpGaD
Icosapent—PPARG—Metabolism—RRM2—uterine cancer	0.000164	0.000501	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—KRAS—uterine cancer	0.000164	0.000499	CbGpPWpGaD
Icosapent—PPARG—Circadian rythm related genes—TP53—uterine cancer	0.000163	0.000497	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	0.000162	0.000494	CbGpPWpGaD
Icosapent—PPARG—Metabolism—DCN—uterine cancer	0.00016	0.000487	CbGpPWpGaD
Icosapent—FADS1—Metabolism—EP300—uterine cancer	0.000159	0.000485	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—ESR2—uterine cancer	0.000157	0.000478	CbGpPWpGaD
Icosapent—PPARD—Metabolism—MTHFR—uterine cancer	0.000152	0.000464	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—PTEN—uterine cancer	0.000151	0.000459	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—PTEN—uterine cancer	0.000151	0.000459	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—PIK3CA—uterine cancer	0.00015	0.000459	CbGpPWpGaD
Icosapent—PPARG—Metabolism—CYP11A1—uterine cancer	0.00015	0.000458	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	0.00015	0.000458	CbGpPWpGaD
Icosapent—PTGS2—Disease—RNF43—uterine cancer	0.000149	0.000453	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—ERBB2—uterine cancer	0.000148	0.000451	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—EP300—uterine cancer	0.000144	0.000438	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—EP300—uterine cancer	0.000144	0.000438	CbGpPWpGaD
Icosapent—PPARG—Metabolism—AKR1C3—uterine cancer	0.000142	0.000433	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	0.000142	0.000433	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—PIK3CA—uterine cancer	0.00014	0.000428	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CXCL8—uterine cancer	0.00014	0.000427	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—AKR1B1—uterine cancer	0.00014	0.000426	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—STAR—uterine cancer	0.00014	0.000426	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—HRAS—uterine cancer	0.000139	0.000424	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—TP53—uterine cancer	0.000139	0.000423	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	0.000138	0.000422	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—POLD1—uterine cancer	0.000138	0.000421	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000138	0.000421	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CDKN1B—uterine cancer	0.000137	0.000417	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—ERBB2—uterine cancer	0.000136	0.000416	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—AKT1—uterine cancer	0.000135	0.000413	CbGpPWpGaD
Icosapent—PPARD—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	0.000134	0.000409	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	0.000132	0.000402	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CTNNB1—uterine cancer	0.000129	0.000394	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—AKR1C1—uterine cancer	0.000129	0.000394	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—CDKN2B—uterine cancer	0.000128	0.000389	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—PTEN—uterine cancer	0.000126	0.000384	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	0.000125	0.000381	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—AKT1—uterine cancer	0.000123	0.000375	CbGpPWpGaD
Icosapent—PTGS2—Disease—AKR1C1—uterine cancer	0.000122	0.000373	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—EP300—uterine cancer	0.00012	0.000366	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—CTNNB1—uterine cancer	0.000119	0.000364	CbGpPWpGaD
Icosapent—FADS1—Metabolism—PIK3CA—uterine cancer	0.000118	0.000358	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—SMAD3—uterine cancer	0.000116	0.000355	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—RRM2—uterine cancer	0.000115	0.000351	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—AKT1—uterine cancer	0.000115	0.000349	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—VEGFA—uterine cancer	0.000114	0.000347	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—NRAS—uterine cancer	0.000112	0.000343	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—DCN—uterine cancer	0.000112	0.000341	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—EP300—uterine cancer	0.000111	0.000338	CbGpPWpGaD
Icosapent—PPARG—Metabolism—STK11—uterine cancer	0.000111	0.000337	CbGpPWpGaD
Icosapent—PPARG—Metabolism—CYP19A1—uterine cancer	0.000111	0.000337	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—POLD1—uterine cancer	0.00011	0.000334	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—PIK3CA—uterine cancer	0.000106	0.000324	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—PIK3CA—uterine cancer	0.000106	0.000324	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	0.000106	0.000324	CbGpPWpGaD
Icosapent—PTGS2—Disease—DCN—uterine cancer	0.000106	0.000323	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CYP11A1—uterine cancer	0.000105	0.000321	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—VEGFA—uterine cancer	0.000105	0.00032	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	0.000104	0.000317	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—NRAS—uterine cancer	0.000104	0.000316	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—AKR1C1—uterine cancer	0.000103	0.000313	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—AKR1C3—uterine cancer	9.95e-05	0.000303	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.9e-05	0.000302	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	9.75e-05	0.000297	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—KRAS—uterine cancer	9.67e-05	0.000295	CbGpPWpGaD
Icosapent—FADS1—Metabolism—AKT1—uterine cancer	9.6e-05	0.000293	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—ESR1—uterine cancer	9.5e-05	0.00029	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	9.44e-05	0.000288	CbGpPWpGaD
Icosapent—PTGS2—Disease—AKR1C3—uterine cancer	9.43e-05	0.000287	CbGpPWpGaD
Icosapent—PTGS2—Disease—HMGA1—uterine cancer	9.19e-05	0.00028	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—RRM2—uterine cancer	9.14e-05	0.000279	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—KRAS—uterine cancer	8.93e-05	0.000272	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—PIK3CA—uterine cancer	8.89e-05	0.000271	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—DCN—uterine cancer	8.87e-05	0.000271	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—AKT1—uterine cancer	8.68e-05	0.000265	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—AKT1—uterine cancer	8.68e-05	0.000265	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—TP53—uterine cancer	8.6e-05	0.000262	CbGpPWpGaD
Icosapent—PPARD—Metabolism—PTEN—uterine cancer	8.47e-05	0.000258	CbGpPWpGaD
Icosapent—PTGS2—Disease—FBXW7—uterine cancer	8.4e-05	0.000256	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CYP11A1—uterine cancer	8.36e-05	0.000255	CbGpPWpGaD
Icosapent—PPARG—Metabolism—MTHFR—uterine cancer	8.31e-05	0.000253	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—HRAS—uterine cancer	8.22e-05	0.000251	CbGpPWpGaD
Icosapent—PPARD—Metabolism—EP300—uterine cancer	8.08e-05	0.000246	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	7.97e-05	0.000243	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—AKR1C3—uterine cancer	7.89e-05	0.000241	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—STK11—uterine cancer	7.75e-05	0.000236	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CYP19A1—uterine cancer	7.75e-05	0.000236	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—HRAS—uterine cancer	7.59e-05	0.000231	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.32e-05	0.000223	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.27e-05	0.000222	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—AKT1—uterine cancer	7.26e-05	0.000221	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.94e-05	0.000212	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—AKT1—uterine cancer	6.7e-05	0.000204	CbGpPWpGaD
Icosapent—PTGS2—Disease—CDKN2B—uterine cancer	6.58e-05	0.000201	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—AKT1—uterine cancer	6.28e-05	0.000191	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—STK11—uterine cancer	6.15e-05	0.000188	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CYP19A1—uterine cancer	6.15e-05	0.000188	CbGpPWpGaD
Icosapent—PTGS2—Disease—SMAD3—uterine cancer	6.01e-05	0.000183	CbGpPWpGaD
Icosapent—PPARD—Metabolism—PIK3CA—uterine cancer	5.97e-05	0.000182	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—MTHFR—uterine cancer	5.82e-05	0.000178	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.77e-05	0.000176	CbGpPWpGaD
Icosapent—PTGS2—Disease—FGFR2—uterine cancer	5.73e-05	0.000175	CbGpPWpGaD
Icosapent—PTGS2—Disease—MTHFR—uterine cancer	5.52e-05	0.000168	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.51e-05	0.000168	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.13e-05	0.000156	CbGpPWpGaD
Icosapent—PPARD—Metabolism—AKT1—uterine cancer	4.88e-05	0.000149	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PTEN—uterine cancer	4.62e-05	0.000141	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—MTHFR—uterine cancer	4.62e-05	0.000141	CbGpPWpGaD
Icosapent—PPARG—Metabolism—EP300—uterine cancer	4.41e-05	0.000134	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.07e-05	0.000124	CbGpPWpGaD
Icosapent—PTGS2—Disease—ERBB2—uterine cancer	3.6e-05	0.00011	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—AKT1—uterine cancer	3.43e-05	0.000105	CbGpPWpGaD
Icosapent—PTGS2—Disease—CDKN1B—uterine cancer	3.33e-05	0.000102	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PIK3CA—uterine cancer	3.26e-05	9.95e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PTEN—uterine cancer	3.24e-05	9.88e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—CTNNB1—uterine cancer	3.15e-05	9.61e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—EP300—uterine cancer	3.09e-05	9.42e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—PTEN—uterine cancer	3.07e-05	9.36e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—EP300—uterine cancer	2.93e-05	8.93e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—NRAS—uterine cancer	2.74e-05	8.35e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—AKT1—uterine cancer	2.66e-05	8.13e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PTEN—uterine cancer	2.57e-05	7.84e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—EP300—uterine cancer	2.45e-05	7.48e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—KRAS—uterine cancer	2.36e-05	7.19e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PIK3CA—uterine cancer	2.28e-05	6.97e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—PIK3CA—uterine cancer	2.17e-05	6.61e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—HRAS—uterine cancer	2e-05	6.11e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—AKT1—uterine cancer	1.87e-05	5.69e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PIK3CA—uterine cancer	1.81e-05	5.53e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—AKT1—uterine cancer	1.77e-05	5.4e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—AKT1—uterine cancer	1.48e-05	4.52e-05	CbGpPWpGaD
